Achmea Investment Management B.V. Abb Vie Inc. Transaction History

Achmea Investment Management B.V.

$6.06 Billion
Q3 2024

A detailed history of Achmea Investment Management B.V. transactions in Abb Vie Inc. stock. As of the latest transaction made, Achmea Investment Management B.V. holds 336,120 shares of ABBV stock, worth $59 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

336,120

Previous 326,625 2.91%

Holding current value

$59 Million

Previous $56 Million 18.48%

% of portfolio

1.09%

Previous 1.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $1.56 Million - $1.89 Million	9,495 Added 2.91%	336,120 $66.4 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $2.83 Million - $3.31 Million	18,304 Added 5.94%	326,625 $56 Million
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $6.15 Million - $7.01 Million	38,470 Added 14.26%	308,321 $56.1 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $2.2 Million - $2.48 Million	-16,009 Reduced 5.6%	269,851 $41.8 Million
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $284,279 - $329,095	-2,128 Reduced 0.74%	285,860 $42.6 Million
Q2 2023 Jul 24, 2023	BUY	$132.51 - $164.9 $4.45 Million - $5.54 Million	33,590 Added 13.2%	287,988 $38.8 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $3.16 Million - $3.64 Million	21,847 Added 9.39%	254,398 $40.5 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $715,754 - $858,377	5,175 Added 2.28%	232,551 $35.2 Million
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $30.5 Million - $35 Million	227,376 New	227,376 $30.5 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $26.6 Million - $33.8 Million	-193,214 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $3.41 Million - $4.23 Million	25,860 Added 15.45%	193,214 $31.3 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $3.98 Million - $5.04 Million	37,093 Added 28.48%	167,354 $22.7 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $2.51 Million - $2.85 Million	-23,575 Reduced 15.32%	130,261 $14.1 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $1.93 Million - $2.15 Million	-18,384 Reduced 10.67%	153,836 $17.3 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $1.76 Million - $1.94 Million	-17,222 Reduced 9.09%	172,220 $18.6 Million
Q4 2020 Feb 22, 2021	BUY	$80.49 - $108.67 $471,590 - $636,697	5,859 Added 3.19%	189,442 $20.3 Million
Q3 2020 Nov 02, 2020	SELL	$85.91 - $100.83 $29.6 Million - $34.8 Million	-344,770 Reduced 65.25%	183,583 $16.1 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $38.8 Million - $51.9 Million	528,353 New	528,353 $51.9 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $9.76 Million - $14.8 Million	-151,369 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $2.23 Million - $2.79 Million	-30,924 Reduced 16.96%	151,369 $13.4 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $991,620 - $1.19 Million	15,745 Added 9.45%	182,293 $13.8 Million
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $158,534 - $202,643	2,413 Added 1.47%	166,548 $12.1 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $216,840 - $255,210	-2,811 Reduced 1.68%	164,135 $13.2 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $7.07 Million - $8.72 Million	-90,788 Reduced 35.23%	166,946 $15.4 Million
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $2.52 Million - $2.8 Million	-28,351 Reduced 9.91%	257,734 $24.4 Million
Q2 2018 Jul 27, 2018	BUY	$89.78 - $106.23 $3.96 Million - $4.68 Million	44,075 Added 18.21%	286,085 $26.5 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $1.38 Million - $1.85 Million	-15,023 Reduced 5.84%	242,010 $22.9 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $12.6 Million - $13.8 Million	140,860 Added 121.25%	257,033 $24.9 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $113,156 - $144,536	1,620 Added 1.41%	116,173 $10.3 Million
Q2 2017 Aug 29, 2017	BUY	N/A	114,553	114,553 $8.3 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account

Achmea Investment Management B.V. Abb Vie Inc. Transaction History